Rare diseases
Investigational molecules
Locations
Portway Building, Granta Park, Great Abington, CB21 6GS, United Kingdom
Bicycletx Limited focuses on advanced malignancies across multiple solid-tumor settings, with research centred on cancers that express specific tumor-associated targets.
Its clinical portfolio includes studies in advanced breast cancer, non-small cell lung cancer, and other difficult-to-treat malignant diseases.
Bicycletx Limited runs clinical trials in conditions such as Transitional cell carcinoma, Non-small cell lung cancer stage IV, Non-small cell lung cancer metastatic, Breast cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
SpainStudy of Zelenectide Pevedotin in Adults with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer with NECTIN4 Amplification
FranceStudy of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification
BelgiumStudy of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
AustriaStudy of BT5528 alone and with nivolumab in patients with advanced solid tumors that have EphA2 protein expression
BelgiumFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
